Semaglutide

As a Zepbound user, I'm what they call a "super responder." In six months, I lost about 100 pounds. Now, there are tests under a science...

GERD is about as unpleasant as it sounds, and new research shows there could be an increased risk for it among certain people taking...

You see all the before-and-after photos, the viral weight loss success stories, the "I lost 40 pounds in three months" reels. But that's...

On June 17, 2025, the announcement of a partnership between 9amHealth and Mark Cuban's Cost Plus crossed the news wires. The news release reads, in part, "This collaboration brings together Cost Plus Drugs' groundbreaking transparent pricing model and 9amHealth's high-touch, at a time where patient demand and rising medical costs have come to a head."

It looked like clickbait. An article about man noticing at least an inch or more length in their penis after losing weight on GLP-1s like Ozempic. In fact, it's now nicknamed Ozempic Penis or (my favorite) OzemDick. Could a weight loss medication also contribute to male enhancement?

We keep hearing that GLP-1s are changing the way Americans eat, but most coverage still treats the average user like a faceless calorie counter. That’s not the story. New research from IFF breaks down the GLP-1 diet trends.

GLP-1 medications like Ozempic and Zepbound are best known for helping with blood sugar and weight, but researchers are starting to...

You started Ozempic (or Zepbound, or Wegovy) to feel better in your body, yet now you're mid-panic, wondering why so much hair is falling out. It leads many to believe that Ozempic or Zepbound causes hair loss. Some even consider stopping GLP-1 meds because of it. However, what's really causing the hair loss isn't as simple as a medication. Here's what you can do now to stop it from happening in the future.

If this is your first time using injectable medications like GLP-1s, it's tempting to toss the needle or pen in the trash after use. Don’t. Knowing how to safely dispose of needles after your weekly dose is vital for safety and legality.

If you’ve started taking Ozempic, Wegovy, Zepbound, or Mounjaro and suddenly feel like you can’t warm up, welcome to the club. Feeling...

How GLP-1 Receptor Agonists Affect Contraceptive Effectiveness—and What to Do About It If you’re on or considering a GLP-1 medication...

This question comes from one of the GLP-1 Newsroom readers. She wants to start back up on Ozempic after she gives birth, but can she take Ozempic while breastfeeding? I decided to do some digging and get all the information in one place to help other moms-to-be looking to rejoin their health program as soon as it is safe for momma and baby.

You’ve probably heard the term metabolic syndrome tossed around lately—on wellness podcasts, in doctors’ offices, even on TikTok. It sounds serious (it is), but also vague (it kind of is). Is it diabetes? A slow metabolism? Is it just another name for being overweight? Not exactly. In this article, we'll explore what metabolic syndrome is, its risk factors

You can't turn a corner or scroll a social media site without seeing an ad or a post about someone taking GLP-1 meds like Ozempic or Wegovy. Most research shows one in eight people have tried them or is currently on them. Now, a new GLP-1 map shows a state-by-state breakdown of how many people are using these medications.

In a major shake-up that’s bound to impact millions of patients, CVS Caremark is cutting ties with Eli Lilly’s weight loss drug Zepbound—and making Novo Nordisk’s Wegovy the go-to GLP-1 for obesity treatment. If your insurance runs through CVS Caremark, here’s what’s changing, why it’s happening, and what you should do next.

The landscape of diabetes and obesity management is on the cusp of a significant transformation, driven by the development of oral...

The World Health Organization (WHO) is getting ready to make a move that could reshape how the world handles obesity. For the first time,...

With demand for GLP-1 medications like semaglutide and tirzepatide soaring, clinical trials have quietly become one of the only ways some people can access treatment, especially if they’re uninsured or can’t afford retail prices. But before you go signing up for an experimental dose of the next Ozempic or peptide agonist, there are a few important things to understand. In this article, we'll talk about what clinical trials are, their pros and cons, what to expect, and how to

What I found was both wild and well-documented: the gut—yes, your gut—may be deeply involved in how osteoarthritis develops and how it could be treated. A hormone called GLP-1, best known for regulating digestion and appetite, might also protect cartilage and reduce joint inflammation. Researchers call it the gut-joint axis, and it’s changing the way we think about osteoarthritis.

The window for GLP-1 compounders to tap dance around the compounding ban is almost closed — and anyone still trying to squeeze through could end up with some bruised fingers. A federal court ruling has backed the FDA’s determination that shortages of Wegovy and Ozempic are officially over, setting up a sharp end to the era of legally available compounded GLP-1s.